Healthcare provider profile · identity verified

Jeffrey Scott Boruff, M.D.

Allopathic & Osteopathic Physicians|Internal Medicine · KNOXVILLE, TN · NPI 1922057223

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Jeffrey Scott Boruff, M.D. received $37.70 in general payments during 2025 across 2 reported records.

Boehringer Ingelheim Pharmaceuticals, Inc. accounted for 100.0% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 1 associated product.

A separate comparison found the same explicitly named product in public Medicare Part D data: Jardiance.

Boehringer Ingelheim Pharmaceuticals, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 123636 records involving 49438 distinct recipient NPIs. Public Medicare Part D data also shows 141 claims for Jardiance by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$37.70

2 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Boehringer Ingelheim Pharmaceuticals, Inc.	Unresolved — no canonical attribution shown	$37.70	100.0%	2	2025

What were the payments for?

Payment categories

Category	Amount	Records
Education	$37.70	2

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
JARDIANCE Normalized: jardiance	Drug	Boehringer Ingelheim Pharmaceuticals, Inc.	$37.70	2	2025
Source payment records 2025-03-24 · Boehringer Ingelheim Pharmaceuticals, Inc. · $18.85 · Open Payments source 2025-05-28 · Boehringer Ingelheim Pharmaceuticals, Inc. · $18.85 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
JARDIANCE jardiance	2025	Jardiance	2024	141	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Boehringer Ingelheim Pharmaceuticals, Inc. Exact reporting entity; no affiliate inference	2025	JARDIANCE open payments reported associated product	CMS Open Payments — General Payments 123636 supporting records · 49438 recipient NPIs · example record 1221811583	Jardiance · 2024 Exact normalized brand match · 1 Part D row	141	43

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	1442	414
Amlodipine Besylate	Amlodipine Besylate	910	259
Levothyroxine Sodium	Levothyroxine Sodium	823	219
Atorvastatin Calcium	Atorvastatin Calcium	776	216
Olmesartan Medoxomil	Olmesartan Medoxomil	776	220
Pantoprazole Sodium	Pantoprazole Sodium	652	189
Omeprazole	Omeprazole	578	177
Metformin Hcl Er	Metformin Hcl	499	174
Metoprolol Succinate	Metoprolol Succinate	457	130
Mounjaro	Tirzepatide	416	85
Valsartan	Valsartan	388	117
Eliquis	Apixaban	376	100
Escitalopram Oxalate	Escitalopram Oxalate	370	117
Trazodone Hcl	Trazodone Hcl	346	110
Gabapentin	Gabapentin	344	82
Tamsulosin Hcl	Tamsulosin Hcl	303	97
Ozempic	Semaglutide	299	77
Clopidogrel	Clopidogrel Bisulfate	292	73
Meloxicam	Meloxicam	290	99
Losartan Potassium	Losartan Potassium	288	93
Carvedilol	Carvedilol	282	84
Lisinopril	Lisinopril	277	81
Duloxetine Hcl	Duloxetine Hcl	247	62
Pravastatin Sodium	Pravastatin Sodium	247	60
Montelukast Sodium	Montelukast Sodium	246	77
Glimepiride	Glimepiride	239	76
Simvastatin	Simvastatin	232	67
Bupropion Xl	Bupropion Hcl	224	65
Allopurinol	Allopurinol	220	63
Hydralazine Hcl	Hydralazine Hcl	201	56
Alprazolam	Alprazolam	196	57
Metformin Hcl	Metformin Hcl	196	64
Alendronate Sodium	Alendronate Sodium	194	59
Furosemide	Furosemide	187	67
Metoprolol Tartrate	Metoprolol Tartrate	186	56
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	186	63
Ezetimibe	Ezetimibe	182	55
Fluticasone Propionate	Fluticasone Propionate	178	77
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	176	52
Zolpidem Tartrate	Zolpidem Tartrate	174	33
Donepezil Hcl	Donepezil Hcl	170	58
Tizanidine Hcl	Tizanidine Hcl	159	59
Sertraline Hcl	Sertraline Hcl	158	45
Celecoxib	Celecoxib	157	56
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	157	46
Potassium Chloride	Potassium Chloride	156	57
Esomeprazole Magnesium	Esomeprazole Magnesium	141	43
Jardiance	Empagliflozin	141	43
Hydroxyzine Hcl	Hydroxyzine Hcl	138	46
Tramadol Hcl	Tramadol Hcl	135	29
Synthroid	Levothyroxine Sodium	132	34
Doxazosin Mesylate	Doxazosin Mesylate	129	39
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	129	27
Spironolactone	Spironolactone	127	37
Famotidine	Famotidine	124	33
Nebivolol Hcl	Nebivolol Hcl	120	33
Buspirone Hcl	Buspirone Hcl	118	31
Prednisone	Prednisone	108	82
Tresiba Flextouch U-200	Insulin Degludec	108	33
Repatha Sureclick	Evolocumab	98	17
Oxybutynin Chloride Er	Oxybutynin Chloride	97	29
Memantine Hcl	Memantine Hcl	95	33
Quetiapine Fumarate	Quetiapine Fumarate	92	22
Ropinirole Hcl	Ropinirole Hcl	92	26
Fluoxetine Hcl	Fluoxetine Hcl	89	24
Citalopram Hbr	Citalopram Hydrobromide	88	22
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	86	30
Myrbetriq	Mirabegron	86	29
Testosterone	Testosterone	86	22
Testosterone Cypionate	Testosterone Cypionate	86	28
Venlafaxine Hcl Er	Venlafaxine Hcl	85	21
Atenolol	Atenolol	83	22
Clonidine Hcl	Clonidine Hcl	83	34
Azelastine Hcl	Azelastine Hcl	81	37
Albuterol Sulfate Hfa	Albuterol Sulfate	80	49
Pioglitazone Hcl	Pioglitazone Hcl	80	21
Irbesartan	Irbesartan	76	17
Hydrochlorothiazide	Hydrochlorothiazide	75	28
Propranolol Hcl Er	Propranolol Hcl	75	26
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	71	21
Bupropion Hcl Sr	Bupropion Hcl	69	18
Clonazepam	Clonazepam	69	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	69	23
Farxiga	Dapagliflozin Propanediol	66	13
Valacyclovir	Valacyclovir Hcl	63	26
Breo Ellipta	Fluticasone/Vilanterol	61	19
Estradiol	Estradiol	60	18
Linzess	Linaclotide	58	15
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	58	17
Repatha Syringe	Evolocumab	57	12
Azithromycin	Azithromycin	56	48
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	56	17
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	55	22
Xarelto	Rivaroxaban	53	16
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	52	19
Janumet Xr	Sitagliptin Phos/Metformin Hcl	52	15
Januvia	Sitagliptin Phosphate	52	12
Telmisartan	Telmisartan	52	12
Janumet	Sitagliptin Phos/Metformin Hcl	51	suppressed
Baclofen	Baclofen	45	11
Entresto	Sacubitril/Valsartan	45	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	44	12
Primidone	Primidone	44	17
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	44	41
Fenofibrate	Fenofibrate	43	11
Novolog Flexpen	Insulin Aspart	41	18
Ramipril	Ramipril	41	suppressed
Verapamil Er	Verapamil Hcl	41	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	40	31
Lansoprazole	Lansoprazole	40	suppressed
Ondansetron Odt	Ondansetron	40	19
Ondansetron Hcl	Ondansetron Hcl	39	23
Terbinafine Hcl	Terbinafine Hcl	39	20
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	38	12
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	38	13
Warfarin Sodium	Warfarin Sodium	37	suppressed
Finasteride	Finasteride	36	13
Triamcinolone Acetonide	Triamcinolone Acetonide	35	28
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	32	27
Emgality Pen	Galcanezumab-Gnlm	32	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	32	11
Methocarbamol	Methocarbamol	32	suppressed
Mirtazapine	Mirtazapine	30	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	29	suppressed
Lovastatin	Lovastatin	29	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	28	suppressed
Fluconazole	Fluconazole	28	21
Mupirocin	Mupirocin	28	25
Bumetanide	Bumetanide	27	suppressed
Benazepril Hcl	Benazepril Hcl	26	suppressed
Praluent Pen	Alirocumab	26	suppressed
Colesevelam Hcl	Colesevelam Hcl	24	suppressed
Enalapril Maleate	Enalapril Maleate	24	suppressed
Glipizide	Glipizide	24	12
Aripiprazole	Aripiprazole	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	23	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	23	15
Lorazepam	Lorazepam	23	suppressed
Rivastigmine	Rivastigmine	23	suppressed
Chlorthalidone	Chlorthalidone	22	suppressed
Clonidine	Clonidine	22	suppressed
Dexlansoprazole Dr	Dexlansoprazole	22	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Trimethoprim	Trimethoprim	22	suppressed
Verapamil Sr	Verapamil Hcl	22	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	21	suppressed
Lamotrigine	Lamotrigine	21	suppressed
Nifedipine Er	Nifedipine	21	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	21	12
Humalog Kwikpen U-100	Insulin Lispro	20	suppressed
Pregabalin	Pregabalin	20	suppressed
Topiramate	Topiramate	20	suppressed
Dutasteride	Dutasteride	19	suppressed
Ipratropium Bromide	Ipratropium Bromide	19	11
Brilinta	Ticagrelor	18	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	18	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	18	16
Eszopiclone	Eszopiclone	18	suppressed
Febuxostat	Febuxostat	18	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	18	suppressed
Minocycline Hcl	Minocycline Hcl	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Sucralfate	Sucralfate	18	11
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Tresiba Flextouch U-100	Insulin Degludec	18	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	17	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	17	11
Hydrocortisone	Hydrocortisone	17	12
Levetiracetam	Levetiracetam	17	suppressed
Livalo	Pitavastatin Calcium	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	16	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	15	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	15	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	14	suppressed
Gemtesa	Vibegron	14	suppressed
Glipizide Er	Glipizide	14	suppressed
Levofloxacin	Levofloxacin	14	14
Lidocaine	Lidocaine	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	12
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Spiriva Respimat	Tiotropium Bromide	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Belsomra	Suvorexant	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	13	11
Colestipol Hcl	Colestipol Hcl	13	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	13	suppressed
Fenofibrate	Fenofibrate,micronized	13	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	13	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Memantine Hcl Er	Memantine Hcl	13	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	13	suppressed
Nystatin	Nystatin	13	suppressed
Raloxifene Hcl	Raloxifene Hcl	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Pen Needle	Pen Needle, Diabetic	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Folic Acid	Folic Acid	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Methylprednisolone	Methylprednisolone	11	suppressed
Minoxidil	Minoxidil	11	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	11	suppressed
Teriparatide	Teriparatide	11	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$37.70 · 2 records	Boehringer Ingelheim Pharmaceuticals, Inc.	JARDIANCE	1	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Jardiance play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with Boehringer Ingelheim Pharmaceuticals, Inc.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error